Skip to main content

Antipsychotic Use in Persons with Dementia

CBE ID
2111
Endorsed
New or Maintenance
Is Under Review
No
Measure Description

The percentage of individuals 65 years and older with dementia who are receiving an antipsychotic medication without evidence of a psychotic disorder or related condition.

A lower rate indicates better performance.

  • Measure Type
    Electronic Clinical Quality Measure (eCQM)
    Level Of Analysis
    Data dictionary not attached
    No
    Numerator

    The number of individuals from the denominator who had one or more prescription claims and more than 30 days’ supply for any antipsychotic medication AND do not have a diagnosis of schizophrenia, bipolar disorder, Huntington’s disease or Tourette’s Syndrome during the measurement year.

    Denominator

    Individuals 65 years and older as of the first day of the measurement year, meeting continuous enrollment criteria (the measurement year, with one allowable gap), and with at least one of the following during the measurement year:
    • Dementia diagnosis
    • Two or more prescription claims and more than 60 days’ supply for a cholinesterase inhibitor or NMDA receptor antagonist.

    Exclusions

    N/A

    All information required to stratify the measure results
    Off
    All information required to stratify the measure results
    Off
    Testing Data Sources
  • Risk adjustment approach
    Off
    Risk adjustment approach
    Off
    Conceptual model for risk adjustment
    Off
    Conceptual model for risk adjustment
    Off
  • Most Recent Endorsement Activity
    Measure Retired and Endorsement Removed Neurology Fall Cycle 2019
    Initial Endorsement
    Endorsement Status
    Last Updated
    Removal Date
  • Detailed Measure Specifications
    No
    Logic Model
    Off
    Impact and Gap
    No
    Feasibility assessment methodology and results
    No
    Address health equity
    No
    Measure’s use or intended use
    No
    508 Compliance
    Off